NL-OMON29431招募中不适用
A phase lb feasibility study of the combination of panobinostat and midostaurin in recipients of allogeneic stem cell transplantation with Flt3-ITD AM
HOVON Data Center0 个研究点目标入组 30 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 30
研究概览
简要总结
/A
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Eligibility for registration
- •---------------------------
排除标准
- •Eligibility for registration
- •---------------------------
研究者
相似试验
已完成
不适用
A phase I/II feasibility study of the combination of panobinostat and decitabine prior to donor lymphocyte infusion in recipients of allogeneic stem cell transplantation with poor and very poor-risk AM(very) poor risk AML or RAEB with IPSS >= 1.5NL-OMON20360HOVO100
已完成
不适用
A phase Ib feasibility study of the combination of panobinostat and midostaurin in recipients of allogeneic stem cell transplantation with FLT3-ITD AMAcute myeloid leukemiaAMLNL-OMON48580HOVO15
招募中
Unknown
Mixed methods evaluation of the feasibility, acceptability and adherence of prehabilitation for head and neck cancer patients undergoing radiotherapy.Head and neck cancerMental healthMalnutritionImpaired communicationSarcopeniaimpaired physical functioningRadiotherapyweak swallowing functionCancer - Head and neckDiet and Nutrition - Other diet and nutrition disordersMental Health - Other mental health disordersOral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colonMusculoskeletal - Other muscular and skeletal disordersACTRN12623000770662Peter MacCallum Cancer Centre60
进行中（未招募）
不适用
A study to evaluate the efficacy and safety of combination chemotherapy of panobinostat and decitabine, given after donor stem cell transplantation in patients with (very) poor risk AM(very) poor risk AML or RAEB with IPSS = 1.5MedDRA version: 18.0Level: LLTClassification code 10024329Term: LeukemiaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 18.0Level: PTClassification code 10028533Term: Myelodysplastic syndromeSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2012-003344-74-BEHOVON Foundation100
进行中（未招募）
1 期
A study about the treatment of patients with a specific type of AML with a combination of panobinostat and midostaurin during 1 year after allogeneic stem cell transplantation .EUCTR2017-002335-42-NLHOVON Foundation40